Showing 341 - 360 results of 77,880 for search '(( a e decrease ) OR ( 50 ((((teer decrease) OR (a decrease))) OR (mean decrease)) ))', query time: 1.14s Refine Results
  1. 341

    Overexpression of <i>PF10_0355</i> decreases parasite susceptibility to halofantrine (HFN) and related antimalarials. by Daria Van Tyne (168938)

    Published 2011
    “…Overexpression of <i>PF10_0355</i> decreases parasite susceptibility to (A) HFN and structurally related (B) mefloquine (MFQ) and (C) lumefantrine (LUM). …”
  2. 342
  3. 343
  4. 344

    Blockade of mTORC2 decreased TRPC6-dependent calcium influx in podocytes (confocal microscopy). by Fangrui Ding (659863)

    Published 2014
    “…Each trace represents the mean value that was derived from 3 cells or fields in a single experiment. …”
  5. 345
  6. 346
  7. 347
  8. 348
  9. 349
  10. 350
  11. 351

    Elevated IDO activity in HD mouse brains is decreased by <i>ex-vivo</i> iron chelation. by David W. Donley (3111198)

    Published 2021
    “…<p>Mouse pups were supplemented with carbonyl iron from postnatal days 10–17 and then were sacrificed at 14 weeks of age. <b>A.</b> Striatal IDO activity is increased in N171-82Q HD mice and significantly decreased by <i>ex vivo</i> iron (III) chelation (50 μM deferoxamine). …”
  12. 352
  13. 353

    Beta-catenin signaling is decreased in intermediate progenitor cells. by Christopher A. Mutch (243132)

    Published 2010
    “…<p>(<b>A</b>) Cortex from E14.5 Axin2-d2EGFP transgenic mice stained for GFP (green), Tbr2 (red), and DNA (blue). …”
  14. 354

    Transient neonatal olfactory deprivation causes a persistent decrease in the addition of CR+ PGCs. A by Yasuko Kato (122938)

    Published 2012
    “…. & reopening group was used as a control (control). The number of PGCs was quantified at P61. …”
  15. 355

    Substance P decreases PRL immunoreactivity in human epidermis. by Ewan A. Langan (405804)

    Published 2013
    “…<p>Epidermal PRL IR (black arrows) was examined in full-thickness human skin organ culture. (A) PRL IR in the control group was significantly greater than that in (B) Substance P treated skin. …”
  16. 356
  17. 357
  18. 358
  19. 359
  20. 360

    A functional PSA mimetic peptide (fPSA) prevents glutamate-induced MAP-2 decrease and concomitant changes in SYN and NCAM synaptic patterns and levels. by María Fernanda Podestá (639243)

    Published 2014
    “…(B) Quantification of MAP-2 immunoreactive area showed decreased levels 6 h after glutamate exposure; this decrease was prevented by fPSA. …”